lsalt peptide
Peptideexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 28, 2019 (NCT03772678)
Timeline
Indications
Mechanism of action
- Renal dipeptidaseINHIBITOR
DPEP1 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL5314991 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05879432 | Phase 2 | Sep 30, 2023 | Arch Biopartners Inc. |
| NCT04402957 | Phase 2 | Jul 1, 2020 | Arch Biopartners Inc. |
| NCT03772678 | Early Phase 1 (Phase 1) | Feb 28, 2019 | Arch Biopartners Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arch Biopartners Inc. | For profit | 3 | 3 | 2 | 2019 |
1 organizations
Page 1 / 1